Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The submission is supported by results from the Phase 3b APEX study
cSCC is one of the most common cancers in the U.S. and globally
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Subscribe To Our Newsletter & Stay Updated
